SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-15-000014
Filing Date
2015-12-14
Accepted
2015-12-14 16:25:30
Documents
2
Period of Report
2015-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revance-8xkreinducementpla.htm 8-K 38266
2 EXHIBIT 99.1 exhibit991-amendedandresta.htm EX-99.1 163301
  Complete submission text file 0001479290-15-000014.txt   202753
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 151286246
SIC: 2834 Pharmaceutical Preparations